Member Profile

Founded in 2014, Sinew Pharma is a biopharmaceutical company based at National Biotechnology Reserach Park in Taipei, Taiwan. The company focuses on two major medical need: (NASH) and Liver damage caused by Acetaminophen.
Sinew uses hepatic metabolic enzymes as a platform to perform layers of screening from in-vitro, in-vivo, toxicology, clinical trials, and optimizes the absorption, distribution, and metabolism of drugs. Sinew successfully developed six new drug candidates to treat NASH and to prevent acetaminophen hepatotoxicity.

Product Pipelines

Please move your mouse cursor over abbreviations with periods to see their full names.